Termination factor
In molecular biology, a termination factor is a protein that mediates the termination of RNA transcription by recognizing a transcription terminator and causing the release of the newly made mRNA. This is part of the process that regulates the transcription of RNA to preserve gene expression integrity and are present in both eukaryotes and prokaryotes, although the process in bacteria is more widely understood.[1] The most extensively studied and detailed transcriptional termination factor is the Rho (ρ) protein of E. coli.[2]
Prokaryotic[edit]
Prokaryotes use one type of RNA polymerase, transcribing mRNAs that code for more than one type of protein. Transcription, translation and mRNA degradation all happen simultaneously. Transcription termination is essential to define boundaries in transcriptional units, a function necessary to maintain the integrity of the strands and provide quality control. Termination in E. coli may be Rho dependent, utilizing Rho factor, or Rho independent, also known as intrinsic termination. Although most operons in DNA are Rho independent, Rho dependent termination is also essential to maintain correct transcription.[1]
ρ factor The Rho protein is an RNA translocase that recognizes a cytosine-rich region of the elongating mRNA, but the exact features of the recognized sequences and how the cleaving takes place remain unknown. Rho forms a ring-shaped hexamer and advances along the mRNA, hydrolyzing ATP toward RNA polymerase (5' to 3' with respect to the mRNA).[3][4] When the Rho protein reaches the RNA polymerase complex, transcription is terminated by dissociation of the RNA polymerase from the DNA. The structure and activity of the Rho protein is similar to that of the F1 subunit of ATP synthase, supporting the theory that the two share an evolutionary link.[4]
Rho factor is widely present in different bacterial sequences and is responsible for the genetic polarity in E. coli. It works as a sensor of translational status, inhibiting non-productive transcriptions,[5] suppressing antisense transcriptions and resolving conflicts that happen between transcription and replication.[6] The process of termination by Rho factor is regulated by attenuation and antitermination mechanisms, competing with elongation factors for overlapping utilization sites (ruts and nuts), and depends on how fast Rho can move during the transcription to catch up with the RNA polymerase and activate the termination process.[7]
Inhibition of Rho dependent termination by bicyclomycin is used to treat bacterial infections. The use of this mechanism along with other classes of antibiotics is being studied as a way to address antibiotic resistance, by suppressing the protective factors in RNA transcription while working in synergy with other inhibitors of gene expression such as tetracycline or rifampicin.[8]
Eukaryotic[edit]
The process of transcriptional termination is less understood in eukaryotes, which have extensive post-transcriptional RNA processing, and each of the three types of eukaryotic RNA polymerase have a different termination system.
In RNA polymerase I, Transcription termination factor, RNA polymerase I binds downstream of the pre-rRNA coding regions, causing the dissociation of the RNA polymerase from the template and the release of the new RNA strand.
In RNA polymerase II, the termination occurs via a polyadenylation/cleaving complex. The 3' tail on the ending of the strand is bound at the polyadenylation site, but the strand will continue to code. The newly synthesised ribonucleotides are removed one at a time by the cleavage factors CSTF and CPSF, in a process that is still not fully understood. The remainder of the strand is disengaged by a 5′-exonuclease when the transcription is finished.
RNA polymerase III terminates after a series of uracil polymerization residues in the transcribed mRNA.[1] Unlike in bacteria and in polymerase I, the termination RNA hairpin needs to be upstream to allow for correct cleaving.[9]
See also[edit]
References[edit]
- ^ a b c Lodish H, Berk A, Zipursky SL, et al. (2000). Molecular Cell Biology 4th edition. New York: W. H. Freeman.
- ^ Boudvillain M, Figueroa-Bossi N, Bossi L (April 2013). "Terminator still moving forward: expanding roles for Rho factor". Current Opinion in Microbiology. 16 (2): 118–24. doi:10.1016/j.mib.2012.12.003. PMID 23347833.
- ^ Richardson JP (July 2003). "Loading Rho to terminate transcription". Cell. 114 (2): 157–9. doi:10.1016/s0092-8674(03)00554-3. PMID 12887917.
- ^ a b Brennan CA, Dombroski AJ, Platt T (March 1987). "Transcription termination factor rho is an RNA-DNA helicase". Cell. 48 (6): 945–52. doi:10.1016/0092-8674(87)90703-3. PMID 3030561. S2CID 42011370.
- ^ Roberts JW (April 2019). "Mechanisms of Bacterial Transcription Termination". Journal of Molecular Biology. 431 (20): 4030–4039. doi:10.1016/j.jmb.2019.04.003. PMID 30978344.
- ^ Kriner MA, Sevostyanova A, Groisman EA (August 2016). "Learning from the Leaders: Gene Regulation by the Transcription Termination Factor Rho". Trends in Biochemical Sciences. 41 (8): 690–699. doi:10.1016/j.tibs.2016.05.012. PMC 4967001. PMID 27325240.
- ^ Qayyum MZ, Dey D, Sen R (April 2016). "Transcription Elongation Factor NusA Is a General Antagonist of Rho-dependent Termination in Escherichia coli". The Journal of Biological Chemistry. 291 (15): 8090–108. doi:10.1074/jbc.M115.701268. PMC 4825012. PMID 26872975.
- ^ Malik M, Li L, Zhao X, Kerns RJ, Berger JM, Drlica K (December 2014). "Lethal synergy involving bicyclomycin: an approach for reviving old antibiotics". The Journal of Antimicrobial Chemotherapy. 69 (12): 3227–35. doi:10.1093/jac/dku285. PMC 4228776. PMID 25085655.
- ^ Nielsen S, Yuzenkova Y, Zenkin N (June 2013). "Mechanism of eukaryotic RNA polymerase III transcription termination". Science. 340 (6140): 1577–80. Bibcode:2013Sci...340.1577N. doi:10.1126/science.1237934. PMC 3760304. PMID 23812715.